The medical community is abuzz about Retatrutide 120 , a combination medication showing significant benefits in preliminary trials . This new compound, a glucagon-like peptide-1 receptor agonist alongside a similar agent , appears to effectively decrease body weight and positively affect metabolic markers. Experts are proposing that it may offer a